Finally, presence of IFN autoantibodies has been demonstrated in plasma from up to 10% of cases with severe COVID-19 [4], thereby functionally impairing IFN activities, in the absence of disease-causing genetic variants. The gene discussed is IFNA1; the disease is COVID-19.